🔥🐔 BizChicken 🐔🔥
Companies Similar to Neurocrine Biosciences, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Biogen Inc.
TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS
Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.
About | About | Vision/Values | Leadership | Foundation | Contact | Careers | Careers | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: BIIB
Recent Price: $150.19
Industry: Drug Manufacturers - General
CEO: Mr. Christopher A. Viehbacher
Sector: Healthcare
Employees: 7570
Address: 225 Binney Street, Cambridge, MA 02142
Phone: 617 679 2000
Leadership
- Christopher A. Viehbacher, President and Chief Executive Officer
- Susan H. Alexander, Chief Legal Officer
- Ginger Gregory, Ph.D., Chief Human Resources Officer
- Jane Grogan, Ph.D., Head of Research
- Rachid Izzar, Head of Global Product Strategy & Commercialization
- Adam Keeney, Head of Corporate Development
- Michael McDonnell, Chief Financial Officer
- Nicole Murphy, Head of Pharmaceutical Operations and Technology
- Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
- Alisha Alaimo, President, Head of North America
- Stephen Amato, Head of Investor Relations
- Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
- Fraser Hall, President, Head of Intercontinental Region
- Wolfram Schmidt, President, Head of Europe
- Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
- Caroline Dorsa, Chair of the Board
- Maria C. Freire, Ph.D., Director
- William A. Hawkins, Director
- Susan Langer, Director
- Jesus B. Mantas, Director
- Lloyd B. Minor, M.D., Director
- Monish Patolawala, Director
- Eric K. Rowinsky, M.D., Director
- Stephen A. Sherwin, M.D., Director
Last updated: 2024-12-31
INmune Bio, Inc.
INKmune
INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.
Symbol: INMB
Recent Price: $4.65
Industry: Biotechnology
CEO: Dr. Raymond Joseph Tesi M.D.
Sector: Healthcare
Employees: 11
Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432
Phone: 858 964 3720
Last updated: 2024-12-31
Inhibrx Biosciences, Inc.
Therapeutic Candidates (INBRX-109, INBRX-106)
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops biologic therapeutics for life-threatening conditions, with therapeutic candidates in phase 2 clinical trials targeting various cancers.
Symbol: INBX
Recent Price: $15.14
Industry: Biotechnology
CEO: Mr. Mark Paul Lappe
Sector: Healthcare
Employees: 166
Address: 11025 North Torrey Pines Road, La Jolla, CA 92037
Phone: 858-795-4220
Last updated: 2024-12-31
Neurocrine Biosciences, Inc.
INGREZZA
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for various conditions, focusing on innovative solutions for unmet medical needs.
Symbol: NBIX
Recent Price: $137.06
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Kyle W. Gano Ph.D.
Sector: Healthcare
Employees: 1700
Address: 12780 El Camino Real, San Diego, CA 92130
Phone: 858 617 7600
Last updated: 2024-12-31
Alto Neuroscience, Inc.
ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.
Symbol: ANRO
Recent Price: $4.20
Industry: Biotechnology
CEO: Dr. Amit Etkin M.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 369 South San Antonio Road, Los Altos, CA 94022
Phone: (650) 200-0412
Last updated: 2024-12-31
Enzo Biochem, Inc.
Life Sciences Products
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company specializing in the research, development, manufacture, and marketing of diagnostic and research products using genetic engineering, biotechnology, and molecular biology. It operates through segments focused on Life Sciences Products, Clinical Laboratory Services, and Therapeutics.
About | About | About | About | About | Leadership | Locations | About | About | About | About | Careers | Benefits | Careers | About | Jobs | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | About | About | About | About
Symbol: ENZ
Recent Price: $0.70
Industry: Medical - Diagnostics & Research
CEO: Ms. Kara Cannon
Sector: Healthcare
Employees: 125
Address: 527 Madison Avenue, New York, NY 10022
Phone: 212 583 0100
Last updated: 2024-12-31
ACADIA Pharmaceuticals Inc.
NUPLAZID
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company committed to the development and commercialization of small molecule drugs to treat unmet medical needs in central nervous system disorders. Key products and developments include NUPLAZID for Parkinson's disease-related psychosis and a diverse pipeline addressing Alzheimer's disease, schizophrenia, Rett syndrome, and pain management.
Symbol: ACAD
Recent Price: $16.69
Industry: Biotechnology
CEO: Ms. Catherine E. Owen Adams
Sector: Healthcare
Employees: 597
Address: 12830 El Camino Real, San Diego, CA 92130
Phone: 858 558 2871
Last updated: 2024-12-31
Alzamend Neuro, Inc.
AL001 and AL002
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing products for neurodegenerative and psychiatric disorders. Their pipeline includes AL001 for Alzheimer's and psychiatric disorders, and AL002 for Alzheimer's disease using a novel vaccine approach.
About | About | Contact | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: ALZN
Recent Price: $1.20
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Sector: Healthcare
Employees: 4
Address: 3500 Lenox Road NE, Atlanta, GA 30326
Phone: 844 722 6333
Last updated: 2024-12-31
Anavex Life Sciences Corp.
ANAVEX 2-73
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.
Symbol: AVXL
Recent Price: $11.04
Industry: Biotechnology
CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
Sector: Healthcare
Employees: 40
Address: 51 West 52nd Street, New York, NY 10019
Phone: 844 689 3939
Last updated: 2024-12-31
BeiGene, Ltd.
BRUKINSA, Tislelizumab, REVLIMID, VIDAZA, XGEVA, BLINCYTO, KYPROLIS, SYLVANT, QARZIBA, Pamiparib, Pobevcy
Bei Gene, Ltd. is a biotechnology company focused on discovering, developing, manufacturing, and commercializing a wide range of medicines globally, specializing in oncology treatments and clinical stage drug candidates.
About | About | Vision/Values | About | About | Culture | DEI | Culture | Leadership | About | Contact | Careers | Careers | Careers | Careers | About | About | About | About | About | Jobs | About | About | About
Symbol: BGNE
Recent Price: $183.81
Industry: Biotechnology
CEO: Mr. John V. Oyler
Sector: Healthcare
Employees: 10000
Address: 55 Cambridge Parkway, Cambridge, MA 02142
Phone: 781-801-1800
Leadership
- John V. Oyler, Co-Founder, Chairman and CEO
- Xiaodong Wang, Ph.D., Co-Founder, Chairman of Scientific Advisory Board
- Olivier Brandicourt, M.D., Director
- Margaret Dugan, M.D., Director
- Donald W. Glazer, Director
- Michael Goller, Director
- Anthony Hooper, Director
- Ranjeev Krishana, Director
- Michael Nuoqing Yi, Director
- Alessandro Riva, M.D., Director
- Corsee Sanders, Ph.D., Director
- Shalini Sharp, Director
- Steven Young, Ph.D., Acting Head of Medicinal Chemistry
- Ron Levy, M.D., Scientific Advisory Board
- Neal Rosen, M.D., Ph.D., Scientific Advisory Board
- Charles Sawyers, M.D., Scientific Advisory Board
- David Schenkein, M.D., Scientific Advisory Board
- Melika Davis, SVP & Global Head, Clinical Operations
- Clare Fisher, SVP, Business Development, Licensing, and M&A (ex-China)
- Tony Guo, Ph.D., SVP, Global Statistics & Data Science
- Dany Habr, M.D., Head of Medical Affairs, North America & International Markets
- Graham Hardiman, Global Head of HR
- Shreya Devendra Jani, SVP, Corporate Affairs
- Jaspreet Jaggi, M.D., Ph.D., SVP and Head, Clinical Portfolio Strategy
- Yang Ji, Chief Compliance Officer
- Mark Lanasa, M.D., Ph.D., SVP, Chief Medical Officer, Solid Tumors
- Chan Lee, General Counsel
- Kyu-Sung Lee, Ph.D., SVP, Global Head of Technical Operations and Manufacturing
- Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer
- Kyoung Lim, VP of Supply Chain
- Han Ma, M.D., Ph.D., Chief Safety Officer and SVP, Global Patient Safety
- Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology
- Richard O’Keeffe, Head of Global Quality
- Jurij Petrin, M.D., Head of New Market Development
- Yan Qi, Ph.D., SVP, Head of Public Affairs
- Hongyu Qian, SVP, Medical Affairs
- Jason Radford, SVP, Strategy & Corporate Development
- Anand Reddi, VP, Global Strategic Initiatives and Corporate Operations, Chief of Staff to the CEO
- Adam Roach, VP and Head of Asia Pacific
- Aaron Rosenberg, Chief Financial Officer
- Michael Schoen, Strategic Advisor and Special Assistant to the CEO
- Matt Shaulis, General Manager of North America
- Lai Wang, Ph.D., Global Head of R&D
- Zhiwei Wang, Ph.D., SVP, Research Head of Chemistry
- Beth Wensley, SVP, Head of Portfolio and Program Management
- Kimberly Wolf, SVP, Global Commercial Strategy & Operations
- Xiaobin Wu, Ph.D., President, Chief Operating Officer
- Eva Yin, Chief Commercial Officer, Greater China
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
BioXcel Therapeutics, Inc.
IGALMI
Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.
Symbol: BTAI
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Vimal D. Mehta Ph.D.
Sector: Healthcare
Employees: 74
Address: 555 Long Wharf Drive, New Haven, CT 06511
Phone: 475 238 6837
Last updated: 2024-12-31
Ensysce Biosciences, Inc.
PF614, PF614-MPAR, PF329
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company focused on developing prescription drugs for severe pain relief and opioid overdose protection using proprietary abuse-resistant technologies.
Symbol: ENSC
Recent Price: $8.62
Industry: Biotechnology
CEO: Dr. D. Lynn Kirkpatrick Ph.D.
Sector: Healthcare
Employees: 7
Address: 7946 Ivanhoe Avenue, La Jolla, CA 92037
Phone: 858 263 4196
Last updated: 2024-12-31
INVO Bioscience, Inc.
INVOcell
INVO Bioscience, Inc. is a fertility company providing assisted reproductive technology solutions with its flagship product, INVOcell, promoting in vivo fertilization and early embryo development. The company aims to make fertility care more accessible worldwide.
Symbol: INVO
Recent Price: $0.83
Industry: Medical - Devices
CEO: Mr. Steven M. Shum
Sector: Healthcare
Employees: 25
Address: 5582 Broadcast Court, Sarasota, FL 34240
Phone: 978 878 9505
Last updated: 2024-12-31
Inozyme Pharma, Inc.
INZ-701
Inozyme Pharma, Inc. is a biopharmaceutical company focused on the development of therapeutics for rare disease conditions involving abnormal mineralization, particularly targeting ENPP1 and ABCC6 deficiencies.
Symbol: INZY
Recent Price: $2.82
Industry: Biotechnology
CEO: Dr. Douglas A. Treco Ph.D.
Sector: Healthcare
Employees: 59
Address: 321 Summer Street, Boston, MA 02210
Phone: 857 330 4340
Leadership
- Doug Treco, Ph.D., CEO, Chairman of Board of Directors
- Gayle Gironda, Senior Vice President and Chief People Officer
- Kurt Gunter, M.D., Senior Vice President and Chief Medical Officer
- Soojin Kim, Ph.D., Senior Vice President and Chief Technical Operations Officer
- Yves Sabbagh, Ph.D., Senior Vice President and Chief Scientific Officer, Chair of the Scientific Advisory Board
- Sanjay S. Subramanian, M.S., MBA, Senior Vice President and Chief Financial Officer
- Matt Winton, Ph.D., Senior Vice President and Chief Operating Officer
- Axel Bolte, MBA, Co-founder, Senior Advisor and Member of Board of Directors
- David Thompson, M.A., M.S., Ph.D., Senior Advisor, Member of Scientific Advisory Board
- Sarah Bhagat, Ph.D., Director
- Reinaldo M. Diaz, MBA, Director
- Martin Edwards M.D., MBA, Director
- Erik Harris, MBA, Director
- Rob Hopfner, Rph, Ph.D., MBA, Director
- Edward Mathers, Director
- Lynne Sullivan, MST, Director
Last updated: 2024-12-31
Minerva Neurosciences, Inc.
Roluperidone
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system diseases, including schizophrenia and Parkinson's disease.
Symbol: NERV
Recent Price: $2.29
Industry: Biotechnology
CEO: Dr. Remy Luthringer Ph.D.
Sector: Healthcare
Employees: 9
Address: 1601 Trapelo Road, Waltham, MA 02451
Phone: 617 600 7373
Leadership
- Remy Luthringer, PhD, Executive Chairman of the Board, Chief Executive Officer
- Geoff Race, FCMA, MBA, President
- Michael Davidson, M.D., Chief Medical Officer
- Frederick Ahlholm, CPA, Chief Financial Officer
- Joseph Reilly, Senior Vice President and Chief Operating Officer
- Jay Saoud, PhD, Consultant
- Hans Peter Hasler, Board Member
- Jan van Heek, Board Member
- David Kupfer, MD, Board Member
- Fouzia Laghrissi-Thode, MD, Board Member, Chief Executive Officer of DalCor Pharmaceuticals
Last updated: 2024-12-31
Neurogene Inc.
NGN-401, NGN-101
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases, focusing on gene therapy products like NGN-401 for Rett syndrome and NGN-101 for neuronal ceroid lipofuscinosis subtype 5 batten disease.
About | Contact | Contact | Careers | Jobs | Jobs | Jobs | Benefits | Jobs | Jobs | Jobs | Jobs | Careers | About | About | About
Symbol: NGNE
Recent Price: $22.28
Industry: Biotechnology
CEO: Dr. Rachel L. McMinn Ph.D.
Sector: Healthcare
Employees: 91
Address: 535 W 24th Street, New York, NY 10011
Phone: (877) 237-5020
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
Recursion Pharmaceuticals, Inc.
REC-994
Recursion Pharmaceuticals is a clinical-stage biotechnology company focusing on decoding biology to industrialize drug discovery, integrating technological innovations across multiple disciplines.
Symbol: RXRX
Recent Price: $6.77
Industry: Biotechnology
CEO: Dr. Christopher C. Gibson Ph.D.
Sector: Healthcare
Employees: 500
Address: 41 South Rio Grande Street, Salt Lake City, UT 84101
Phone: 385 269 0203
Last updated: 2024-12-31
IN8bio, Inc.
INB-200, INB-100, INB-400, INB-300
IN8bio, Inc. is a clinical-stage biotechnology company focused on gamma-delta T cell therapies for cancer treatment, with lead products in clinical trials and preclinical development.
Symbol: INAB
Recent Price: $0.27
Industry: Biotechnology
CEO: Mr. Tai-Wei Ho
Sector: Healthcare
Employees: 39
Address: 350 5th Avenue, New York, NY 10118
Phone: 646 600 6438
Last updated: 2024-12-31